The driving force of AD pathology is hypothesized to be the formation of toxic amyloid-β (Aβ) peptides that are cleaved from amyloid precursor protein (APP), the subsequent development of neurofibrillary tangles (NFTs), and the resulting, cascade of secondary pathologies (Lachén-Montes et al., 2016). Here, APP is linked to Alzheimer disease.